These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17994660)

  • 1. Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the series.
    Ceccarelli SM; Schlotterbeck G; Boissin P; Binder M; Buettelmann B; Hanlon S; Jaeschke G; Kolczewski S; Kupfer E; Peters JU; Porter RH; Prinssen EP; Rueher M; Ruf I; Spooren W; Stämpfli A; Vieira E
    ChemMedChem; 2008 Jan; 3(1):136-44. PubMed ID: 17994660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective isolation of in vitro phase II conjugates using a lipophilic anionic exchange solid phase extraction method.
    Gagné S; Laterreur J; Mahrouche L; Sørensen D; Gauthier JY; Truong VL; Chauret N; Lévesque JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 863(2):242-8. PubMed ID: 18262477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-SPE-NMR-MS: a total analysis system for bioanalysis.
    Schlotterbeck G; Ceccarelli SM
    Bioanalysis; 2009 Jun; 1(3):549-59. PubMed ID: 21083152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to perform metabolite screening during the quantitative LC-MS/MS analyses of in vitro metabolic stability samples using a hybrid triple-quadrupole linear ion trap mass spectrometer.
    Shou WZ; Magis L; Li AC; Naidong W; Bryant MS
    J Mass Spectrom; 2005 Oct; 40(10):1347-56. PubMed ID: 16206149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of degradation products in loxoprofen sodium adhesive tapes by liquid chromatography-mass spectrometry and dynamic pressurized liquid extraction-solid-phase extraction coupled to liquid chromatography-nuclear magnetic resonance spectroscopy.
    Murakami T; Kawasaki T; Takemura A; Fukutsu N; Kishi N; Kusu F
    J Chromatogr A; 2008 Oct; 1208(1-2):164-74. PubMed ID: 18778828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metabolite detection and identification in drug discovery via LC-MS/MS with data-dependent scanning and postacquisition data mining.
    Triolo A; Altamura M; Dimoulas T; Guidi A; Lecci A; Tramontana M
    J Mass Spectrom; 2005 Dec; 40(12):1572-82. PubMed ID: 16320289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry.
    Hop CE; Tiller PR; Romanyshyn L
    Rapid Commun Mass Spectrom; 2002; 16(3):212-9. PubMed ID: 11803543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A generic fast solid-phase extraction high-performance liquid chromatography/mass spectrometry method for high-throughput drug discovery.
    Gao L; Cheng X; Zhang J; Burns DJ
    Rapid Commun Mass Spectrom; 2007; 21(21):3497-504. PubMed ID: 17922486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-UV-solid-phase extraction-NMR-MS combined with a cryogenic flow probe and its application to the identification of compounds present in Greek oregano.
    Exarchou V; Godejohann M; van Beek TA; Gerothanassis IP; Vervoort J
    Anal Chem; 2003 Nov; 75(22):6288-94. PubMed ID: 14616013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry.
    Xu R; Manuel M; Cramlett J; Kassel DB
    J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
    Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
    Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling of endocrine-disrupting compounds by on-line cytochrome p450 bioreaction coupled to on-line receptor affinity screening.
    Van Liempd SM; Kool J; Meerman JH; Irth H; Vermeulen NP
    Chem Res Toxicol; 2007 Dec; 20(12):1825-32. PubMed ID: 17975887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining PARAFAC analysis of HPLC-PDA profiles and structural characterization using HPLC-PDA-SPE-NMR-MS experiments: commercial preparations of St. John's Wort.
    Schmidt B; Jaroszewski JW; Bro R; Witt M; Staerk D
    Anal Chem; 2008 Mar; 80(6):1978-87. PubMed ID: 18260653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of high performance liquid chromatography coupled to on-line solid-phase extraction-nuclear magnetic resonance spectroscopy for the analysis of degradation products of V-class nerve agents and nitrogen mustard.
    Mazumder A; Kumar A; Purohit AK; Dubey DK
    J Chromatogr A; 2010 Apr; 1217(17):2887-94. PubMed ID: 20303089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear magnetic resonance (NMR)-based drug metabolite profiling.
    Lenz EM
    Methods Mol Biol; 2011; 708():299-319. PubMed ID: 21207298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.